Keytruda is a brand name for the drug pembrolizumab, which is a type of immunotherapy medication used to treat various types of cancer [1]. According to the official Keytruda website, there are several financial assistance programs available to help eligible patients access Keytruda. These programs include the Merck Patient Assistance Program, which provides free Keytruda to eligible patients who do not have insurance coverage or who cannot afford their co-payments [2]. Additionally, the Merck Access Program offers financial assistance to eligible patients who have commercial insurance but still cannot afford their co-payments or deductibles [3]. However, it is important to note that these programs have specific eligibility criteria and not all patients may qualify for assistance. It is recommended that patients speak with their healthcare provider or contact the Keytruda support team directly to learn more about these programs and their eligibility requirements.

Sources:
[1] DrugPatentWatch. (n.d.). Keytruda. Retrieved from https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA
[2] Keytruda. (n.d.). Financial Support. Retrieved from https://www.keytruda.com/financial-support/
[3] Merck Access Program. (n.d.). Affordability. Retrieved from https://www.merckaccessprogram-keytruda.com/hcc/affordability.html